Arcus Biosciences, Inc. (RCUS)
NYSE·Healthcare·Biotechnology
$26.60
-1.66%
Mkt Cap $3.40B
Analyst Ratings
Buy
6
Hold
2
Sell
0
Price Target (24 analysts)
$31.75
Range $22.00 – $47.00
Implied Upside
+19.4%
Consensus $31.75 vs current $26.60
NYSE·Healthcare·Biotechnology
$26.60
-1.66%
Mkt Cap $3.40B
Buy
6
Hold
2
Sell
0
Price Target (24 analysts)
$31.75
Range $22.00 – $47.00
+19.4%
Consensus $31.75 vs current $26.60